GSS.AX

Healthcare Diagnostics & Research

Genetic Signatures Limited

A$0.08

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

17.94M

Avg Volume

498,304

EPS

-A$0.06

52W High

A$0.43

52W Low

A$0.05

Div. Yield

0.0%

Valuation

Forward P/E

-1.76

P/B Ratio

0.50

P/S Ratio

0.93

EV/EBITDA

0.34

EV/Revenue

-0.20

Margins

Gross Margin 44.5%

Operating Margin (56.4%)

Net Margin (72.5%)

EBITDA Margin (58.3%)

Growth & Returns

Revenue Growth (YoY)

(5.4%)

Return on Equity

(32.6%)

Return on Assets

(17.3%)

Liquidity & Leverage

Current Ratio

13.10

Quick Ratio

10.80

Debt / Equity

0.01

Total Cash

22.09M

Total Debt

310,000

About

Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. The company offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, extended respiratory, atypical respiratory, Measles, Mumps, and Rubella detection kits under the EasyScreen name. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.